Eli Lilly and Company (LLY) is a premier global pharmaceutical leader specializing in developing breakthrough therapies across neuroscience, oncology, immunology, and cardiometabolic health. Today, Lilly is at the forefront of a medical revolution, driven by its leadership in incretin-based medicines for Type 2 diabetes and obesity, such as Mounjaro and Zepbound. Beyond metabolic health, the company is advancing high-impact treatments for Alzheimer’s disease and cancer. Eli Lilly is now, with an agreement ...